Lista de obras - Mitchell K.p. Lai - Dominio Público Uruguay

A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease

artículo científico publicado en 2009

Ageing and the telomere connection: An intimate relationship with inflammation

artículo científico publicado en 2015

Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease

artículo científico publicado en 2007

Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.

artículo científico publicado en 2010

Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients

artículo científico publicado en 2015

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias

artículo científico

An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease.

artículo científico publicado en 2015

Andrographolide attenuates LPS-stimulated up-regulation of C-C and C-X-C motif chemokines in rodent cortex and primary astrocytes

artículo científico publicado en 2016

Andrographolide attenuates interleukin-1β-stimulated upregulation of chemokine CCL5 and glial fibrillary acidic protein in astrocytes

artículo científico publicado en 2014

Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK

artículo científico publicado en 2016

Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease

artículo científico publicado en 2014

Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs

artículo científico publicado en 2016

Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia

artículo científico publicado en 2014

Cdk5-mediated phosphorylation of delta-catenin regulates its localization and GluR2-mediated synaptic activity

artículo científico publicado en 2010

Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice

artículo científico publicado en 2009

Cystathionine β-synthase inhibition is a potential therapeutic approach to treatment of ischemic injury

artículo científico publicado en 2015

Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias.

artículo científico publicado en 2013

Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden

artículo científico publicado en 2013

Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease

artículo científico publicado en 2015

Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease

artículo científico publicado en 2010

Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease

artículo científico publicado en 2006

Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).

artículo científico publicado en 2015

F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy

scientific journal article

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease

artículo científico publicado en 2016

Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease

artículo científico publicado en 2010

Genome-wide profiling of alternative splicing in Alzheimer's disease

artículo científico publicado en 2014

Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia

scientific article published on August 2016

Hippocampal neurofibrillary tangle changes and aggressive behaviour in dementia ⬇️

artículo científico publicado el 8 de diciembre de 2010

Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment

scientific article published on 30 September 2020

Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease

artículo científico publicado en 2005

Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.

artículo científico publicado en 2016

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias

artículo científico publicado en 2016

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex

artículo científico publicado en 2010

Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.

artículo científico publicado en 2005

Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias

artículo científico publicado en 2020

Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis

artículo científico publicado en 2008

Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease

artículo científico publicado en 2004

Low Plasma Ergothioneine Predicts Cognitive and Functional Decline in an Elderly Cohort Attending Memory Clinics

artículo científico publicado en 2022

Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration

artículo científico publicado en 2018

Markers of cardiac dysfunction in cognitive impairment and dementia

artículo científico publicado en 2015

Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease

artículo científico publicado en 2017

Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia.

artículo científico publicado en 2016

NeuroAiD® (MLC601) and amyloid precursor protein processing.

artículo científico publicado en 2013

Neurochemical basis for symptomatic treatment of Alzheimer's disease

artículo científico publicado en 2010

Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia

artículo científico publicado en 2014

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease

artículo científico publicado en 2002

Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias

artículo científico publicado en 2011

Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease

artículo científico publicado en 2003

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias

artículo científico publicado en 2014

Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders

artículo científico publicado en 2016

S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.

artículo científico publicado en 2018

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease

artículo científico publicado en 2006

Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes

artículo científico publicado en 2017

Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology

artículo científico publicado en 2008

Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

artículo científico publicado en 2014

Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients

artículo científico publicado en 2003

Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia

artículo científico publicado en 2018

Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease

artículo científico publicado en 2017

Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations

artículo científico publicado en 2018

Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications

artículo científico publicado en 2018

Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.

artículo científico publicado en 2016

Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease.

artículo científico publicado en 2011

iTRAQ quantitative clinical proteomics revealed role of Na(+)K(+)-ATPase and its correlation with deamidation in vascular dementia.

artículo científico publicado en 2014

Lista de obras de Mitchell K.p. Lai

A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease

Ageing and the telomere connection: An intimate relationship with inflammation

Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease

Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.

Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias

An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease.

Andrographolide attenuates LPS-stimulated up-regulation of C-C and C-X-C motif chemokines in rodent cortex and primary astrocytes

Andrographolide attenuates interleukin-1β-stimulated upregulation of chemokine CCL5 and glial fibrillary acidic protein in astrocytes

Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK

Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease

Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs

Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia

Cdk5-mediated phosphorylation of delta-catenin regulates its localization and GluR2-mediated synaptic activity

Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice

Cystathionine β-synthase inhibition is a potential therapeutic approach to treatment of ischemic injury

Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias.

Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden

Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease

Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease

Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease

Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).

F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease

Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease

Genome-wide profiling of alternative splicing in Alzheimer's disease

Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia

Hippocampal neurofibrillary tangle changes and aggressive behaviour in dementia ⬇️

Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment

Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease

Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex

Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.

Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias

Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis

Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease

Low Plasma Ergothioneine Predicts Cognitive and Functional Decline in an Elderly Cohort Attending Memory Clinics

Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration

Markers of cardiac dysfunction in cognitive impairment and dementia

Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease

Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia.

NeuroAiD® (MLC601) and amyloid precursor protein processing.

Neurochemical basis for symptomatic treatment of Alzheimer's disease

Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease

Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias

Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias

Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders

S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease

Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes

Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology

Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients

Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia

Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease

Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations

Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications

Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.

Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease.

iTRAQ quantitative clinical proteomics revealed role of Na(+)K(+)-ATPase and its correlation with deamidation in vascular dementia.